Breadcrumb Home Spatial Technology Platform Social STP on the Broad patio in the summertim Summer potluck low vibrations. Reunions. Reunions. STP 2022 Secret Santa. Lab members gathering to watch the partial 2024 eclipse at the Broad. The team in 2020 - great work at keeping that distance, everyone. A goodbye party for Serwah Danquah (alumni) before she heads off to grad school at UW. Congrats Serwah. No scout camp can hold us. STP escaped the U-Boat with all that gold. STP (including 5 high school summer interns!) enjoying the sun after lab brunch in the summer of 2023. Congratulations Jax, on presenting a fantastic poster at the 2023 Broad Retreat! STP pulls together some amazing Halloween decor! Murder mystery on the beach. STP goes all out with the Halloween costume. Competing with Granger lab for the Halloween costume glory. Celebrating the Hellos and Goodbye. Important furniture additions to STP’s main office space. Jack’s espresso machine in the office is a crucial element of STP productivity. Food and fun at Cambridgeside. Spatial Technology Platform About Platform capabilities Technologies FAQ Team Social Research Farhi group Lipinski group Fernandez group Erion-Barner group Collaborate with us Join us Latest news News 11.03.2025 Biology of Adversity Project launches at Broad Institute News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry News 10.16.2025 Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer All news
News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy
News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
News 10.16.2025 Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer